Interestingly, treatment of lymphoma cells with the methyl transferase inhibitor DZNeP results in a reduced methylation of Fas-AS1 promoter, a great increase of Fas-AS1 expression and consequently a reduction of sFAS isoform and an increase of mFAS [39]. This evidence concerns the gene FAS and lymphoma.